Lionstone Capital Management Has Upped Holding in Aramark (ARMK); Amgen (AMGN) Holder King Luther Capital Management Increased Holding

Aramark (NYSE:ARMK) Logo

King Luther Capital Management Corp increased its stake in Amgen Inc (AMGN) by 2.03% based on its latest 2018Q1 regulatory filing with the SEC. King Luther Capital Management Corp bought 12,195 shares as the company’s stock declined 5.44% with the market. The institutional investor held 613,654 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $104.62 million, up from 601,459 at the end of the previous reported quarter. King Luther Capital Management Corp who had been investing in Amgen Inc for a number of months, seems to be bullish on the $121.32 billion market cap company. The stock decreased 0.10% or $0.19 during the last trading session, reaching $183.34. About 1.88 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since June 29, 2017 and is uptrending. It has outperformed by 2.11% the S&P500. Some Historical AMGN News: 10/03/2018 – REGENERON, SANOFI SAY PRALUENT PRICING OFFER TO BE TIED TO INDEPENDENT ICER REVIEW OF NEW RISK REDUCTION DATA; 17/05/2018 – FDA OKS AIMOVIG FOR PREVENTIVE TREATMENT OF MIGRAINE IN ADULTS; 29/03/2018 – FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children; 24/04/2018 – Amgen, Inc. Sees 2018 Rev $21.9B-$22.8B; 26/04/2018 – AbbVie’s beat fueled by demand for Humira, Hep C drugs; 25/05/2018 – FDA CONFIRMS ORPHAN DRUG STATUS FOR AMGEN’S ROMIPLOSTIM; 26/04/2018 – Humira Helps AbbVie — Earnings Review; 10/04/2018 – Samsung Bioepis may pay 5% of Humira biosimilar sales as royalty to AbbVie, insiders say; 15/05/2018 – Eli Lilly touts some mixed PhIII results for cluster headaches as Amgen, Novartis prep a market-busting move in migraine $LLY $AMGN $NVS $TEVA; 22/05/2018 – AMGEN INC – ALL OF DIRECTOR NOMINEES WERE RE-ELECTED TO BOARD AT ANNUAL MEETING OF STOCKHOLDERS

Leon Lowenstein increased its stake in Aramark (ARMK) by 15.15% based on its latest 2018Q1 regulatory filing with the SEC. Lionstone Capital Management Llc bought 75,200 shares as the company’s stock declined 7.96% with the market. The hedge fund run by Leon Lowenstein held 571,500 shares of the restaurants company at the end of 2018Q1, valued at $22.61M, up from 496,300 at the end of the previous reported quarter. Lionstone Capital Management Llc who had been investing in Aramark for a number of months, seems to be bullish on the $9.15B market cap company. The stock decreased 0.48% or $0.18 during the last trading session, reaching $37.2. About 2.15 million shares traded or 44.48% up from the average. Aramark (NYSE:ARMK) has risen 4.56% since June 29, 2017 and is uptrending. It has underperformed by 8.01% the S&P500. Some Historical ARMK News: 08/05/2018 – ARAMARK SEES FY ADJ EPS $2.20 TO $2.30, EST. $2.22; 08/05/2018 – ARAMARK 2Q ADJ EPS 48C, EST. 46C; 15/05/2018 – GLENVIEW BOOSTED FDX, CAH, NWL, ARMK, PNR IN 1Q: 13F; 14/03/2018 – Global Contract Catering Market Report 2018-2022 – Key Players Compass Group, Sodexo Group, Elior Group and Aramark are Domating – ResearchAndMarkets.com; 06/03/2018 Aramark Announces Participation in Deutsche Bank’s 2018 Media, Telecom & Business Services Conference; 08/05/2018 – Aramark 2Q EPS 11c; 22/04/2018 – DJ Aramark, Inst Holders, 1Q 2018 (ARMK); 02/04/2018 – Aramark Unveils Extensive Renovations and New Programs, in Advance of 2018 Spring/Summer Travel Season; 08/05/2018 – Aramark 2Q Adj EPS 48c; 24/04/2018 – NJ Warn Notices: Aramark Campus Services, LLC – 06/30/2018

Lionstone Capital Management Llc, which manages about $414.04 million and $220.69M US Long portfolio, decreased its stake in Cannae Hldgs Inc by 356,442 shares to 1.08 million shares, valued at $20.31 million in 2018Q1, according to the filing.

Investors sentiment increased to 1.22 in 2018 Q1. Its up 0.21, from 1.01 in 2017Q4. It improved, as 28 investors sold ARMK shares while 90 reduced holdings. 50 funds opened positions while 94 raised stakes. 225.95 million shares or 1.04% more from 223.63 million shares in 2017Q4 were reported. Massmutual Trust Fsb Adv accumulated 0% or 28 shares. Segall Bryant & Hamill Ltd Liability Corp has invested 0.8% in Aramark (NYSE:ARMK). Massachusetts Svcs Ma invested in 0.17% or 10.26 million shares. Bb&T Secs Llc accumulated 10,661 shares. 11,755 were reported by Metropolitan Life Insurance New York. Point72 Asset Ltd Partnership owns 570,973 shares or 0.09% of their US portfolio. Putnam Fl Mgmt Co holds 0.02% in Aramark (NYSE:ARMK) or 5,606 shares. Gabelli Funds holds 0.01% of its portfolio in Aramark (NYSE:ARMK) for 35,500 shares. Vaughan Nelson Investment Mgmt LP holds 1.29 million shares or 0.63% of its portfolio. Quantbot Technology Limited Partnership holds 53,042 shares. Thornburg Invest Mgmt invested in 631,567 shares or 0.19% of the stock. Morgan Stanley has 480,382 shares for 0.01% of their portfolio. Asset One Commerce Ltd reported 398,653 shares. Pnc Services reported 51,731 shares stake. Axa has 0.07% invested in Aramark (NYSE:ARMK).

Among 15 analysts covering Aramark Holdings Corporation (NYSE:ARMK), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Aramark Holdings Corporation had 40 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, October 16 by Robert W. Baird. The rating was maintained by RBC Capital Markets with “Buy” on Tuesday, November 14. The stock has “Equal Weight” rating by Barclays Capital on Tuesday, January 10. The company was upgraded on Thursday, August 13 by Robert W. Baird. The company was maintained on Monday, September 11 by Robert W. Baird. The stock of Aramark (NYSE:ARMK) has “Buy” rating given on Wednesday, August 9 by RBC Capital Markets. Morgan Stanley maintained Aramark (NYSE:ARMK) rating on Wednesday, January 31. Morgan Stanley has “Equal-Weight” rating and $42 target. The stock of Aramark (NYSE:ARMK) earned “Outperform” rating by Macquarie Research on Friday, August 26. Barclays Capital maintained Aramark (NYSE:ARMK) on Friday, December 22 with “Hold” rating. The stock has “Buy” rating by RBC Capital Markets on Monday, June 26.

Investors sentiment decreased to 0.88 in 2018 Q1. Its down 0.34, from 1.22 in 2017Q4. It is negative, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. Norinchukin Bank The has invested 0.29% in Amgen Inc. (NASDAQ:AMGN). Moreover, Clarivest Asset Mngmt Limited Liability has 1.15% invested in Amgen Inc. (NASDAQ:AMGN). Metropolitan Life owns 114,126 shares. Aull & Monroe Mgmt has invested 1.18% in Amgen Inc. (NASDAQ:AMGN). Stillwater Inv Mngmt Limited Liability Corp reported 1.22% stake. Central Fincl Bank has 1.21% invested in Amgen Inc. (NASDAQ:AMGN) for 28,337 shares. Jane Street Gru Limited reported 18,659 shares stake. Davis R M owns 6,188 shares or 0.04% of their US portfolio. California Pub Employees Retirement holds 1.94M shares or 0.47% of its portfolio. Consolidated Invest Group Ltd Llc owns 17,134 shares or 1.41% of their US portfolio. North Carolina-based Parsec has invested 1.58% in Amgen Inc. (NASDAQ:AMGN). Baxter Bros Inc reported 3,547 shares. Alphaone Invest Svcs Limited Liability Corporation accumulated 2,079 shares. Alta Cap Mngmt Ltd Liability Co has invested 0.02% in Amgen Inc. (NASDAQ:AMGN). Community Tru & Invest stated it has 1,675 shares or 0.03% of all its holdings.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Amgen Inc. (NASDAQ:AMGN) has “Buy” rating given on Tuesday, October 3 by Cowen & Co. The rating was maintained by Credit Suisse on Friday, February 2 with “Neutral”. Mizuho maintained it with “Buy” rating and $19500 target in Friday, July 14 report. The stock has “Buy” rating by Argus Research on Thursday, July 27. Oppenheimer maintained the shares of AMGN in report on Wednesday, July 12 with “Buy” rating. The firm has “Buy” rating by Cowen & Co given on Thursday, July 20. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Jefferies on Tuesday, July 11. On Tuesday, January 23 the stock rating was upgraded by Argus Research to “Buy”. UBS maintained Amgen Inc. (NASDAQ:AMGN) on Wednesday, July 26 with “Neutral” rating. Atlantic Securities initiated Amgen Inc. (NASDAQ:AMGN) on Friday, December 18 with “Overweight” rating.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Investorplace.com which released: “5 Cheap Large Cap Stocks to Buy Now” on June 28, 2018, also Seekingalpha.com with their article: “EC grants full approval for Amgen’s Blincyto” published on June 19, 2018, Benzinga.com published: “Benzinga’s Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut” on June 28, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Seekingalpha.com and their article: “The Best Dividend-Paying Biotech Stocks For Your Portfolio” published on June 25, 2018 as well as Seekingalpha.com‘s news article titled: “Amgen Has Me Worried Therefore Selling Calls” with publication date: May 31, 2018.

King Luther Capital Management Corp, which manages about $16.93 billion and $11.95 billion US Long portfolio, decreased its stake in Newell Brands Inc (NYSE:NWL) by 2.70 million shares to 639,144 shares, valued at $16.29 million in 2018Q1, according to the filing. It also reduced its holding in Prudential Finl Inc (NYSE:PRU) by 23,560 shares in the quarter, leaving it with 259,154 shares, and cut its stake in Mercury Sys Inc (NASDAQ:MRCY).

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart